InterSpace Hip

InterSpace Hip

The first and only commercially available pre-formed spacer technology.

InterSpace® Hip, the first pre-formed temporary hip spacer with gentamicin for two-stage revision arthroplasty, is designed to temporarily replace a total hip arthroplasty (THA) when the implant is removed as a result of infection. InterSpace Hip is a partial load-bearing structure consisting of gentamicin-impregnated PMMA bone cement molded onto a stainless steel reinforcing core.

InterSpace Hip

 

Advantages

  • High Release formulation affords an increased surface area, which allows for greater antimicrobial activity than other treatment options1
  • Maintains joint space and allows limited mobility with partial weight bearing*
  • Improves quality of life between procedures2,3,4
  • Provides predictable, consistent local antibiotic release5
  • Stabilizes or tensions the soft tissues and reduces bone loss between stages, potentially facilitating easier re-implantation during a second stage procedure2,3,6
  • Reduces hospitalization and allows for an early transition to rehabilitation and physical therapy6,7
  • Offers functional success rates equivalent to non-infected revisions.8

 InterSpace Logo
InterSpace® is produced by Tecres® S.p.A., Italy, and
distributed in the United States exclusively by Exactech, Inc

 

 

* Partial weight bearing must be assessed on an individual basis with relation to the anatomic condition of the local bone, bone quality and clinical conditions of the patient during rehabilitation stages. Care must be taken to minimize the risk of damaging bone tissue and the implant through excessive weight bearing or forced mobilization.

 

References

1. Soffiatti R. The preformed spacers: from the idea to the realization of an industrial device. In: Meani E, et al [ed].Infection and local treatment in Orthopedic surgery. Berlin: Springer-Verlag; 2007. 201-4.

2. Burnett S, Kelly M, Hanssen A, Barrack R. Technique and timing of two-stage exchange for infection in TKA. Clin Orthop Relat Res. 2007 Nov;464:164-78.

3. Castelli C, et al. Key points in two-stage revision for infected knee arthroplasty: bone loss, quality of life between stages and surgical approach at second stage. In: Meani E, et al [ed]. Infection and local treatment in orthopedic surgery. Berlin: Springer-Verlag; 2007. 294-301.

4. Su Y, Lee O, Chen W, Chen T. A facile technique to make articulating spacers for infected total knee arthroplasty. J Chin Med Assoc. 2009 Mar;72(3):138-45.

5. Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two stage revision of infected arthroplasty. J Antimicrob Chemother. 2004 Feb;53(2):329-34. E pub 2003 Dec 19.

6. Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006 May;37 Suppl 2:S95-104. Review.

7. Magnan B, et al. Two-stage revision of infected total hip replacement using a preformed, antibiotic-loaded acrylic cement spacer. In: Meani E, et al [ed]. Infection and local treatment in orthopedic surgery. Berlin: Springer- Verlag; 2007. 205-13.

8. Romano CL, Romano D, Logoluso N, Meani E. Aseptic versus septic total hip arthroplasty revision: comparing the results. Poster presented at the 76th Annual American Academy of Orthopaedic Surgeons Meeting; 2009 Feb 25-28; Las Vegas, NV.